GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Suzhou Fushilai Pharmaceutical Co Ltd (SZSE:301258) » Definitions » PS Ratio

Suzhou Fushilai Pharmaceutical Co (SZSE:301258) PS Ratio : 5.63 (As of Jun. 05, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Suzhou Fushilai Pharmaceutical Co PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Suzhou Fushilai Pharmaceutical Co's share price is ¥26.26. Suzhou Fushilai Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥4.67. Hence, Suzhou Fushilai Pharmaceutical Co's PS Ratio for today is 5.63.

The historical rank and industry rank for Suzhou Fushilai Pharmaceutical Co's PS Ratio or its related term are showing as below:

SZSE:301258' s PS Ratio Range Over the Past 10 Years
Min: 4.38   Med: 5.99   Max: 7.65
Current: 5.44

During the past 11 years, Suzhou Fushilai Pharmaceutical Co's highest PS Ratio was 7.65. The lowest was 4.38. And the median was 5.99.

SZSE:301258's PS Ratio is ranked better than
63.1% of 1000 companies
in the Biotechnology industry
Industry Median: 9.29 vs SZSE:301258: 5.44

Suzhou Fushilai Pharmaceutical Co's Revenue per Sharefor the three months ended in Mar. 2024 was ¥1.05. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥4.67.

Warning Sign:

Suzhou Fushilai Pharmaceutical Co Ltd revenue per share has been in decline over the past 3 years.

During the past 12 months, the average Revenue per Share Growth Rate of Suzhou Fushilai Pharmaceutical Co was -26.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was -8.40% per year. During the past 5 years, the average Revenue per Share Growth Rate was -0.80% per year. During the past 10 years, the average Revenue per Share Growth Rate was 9.40% per year.

During the past 11 years, Suzhou Fushilai Pharmaceutical Co's highest 3-Year average Revenue per Share Growth Rate was 31.50% per year. The lowest was -8.40% per year. And the median was 10.70% per year.

Back to Basics: PS Ratio


Suzhou Fushilai Pharmaceutical Co PS Ratio Historical Data

The historical data trend for Suzhou Fushilai Pharmaceutical Co's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suzhou Fushilai Pharmaceutical Co PS Ratio Chart

Suzhou Fushilai Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 5.95 6.07

Suzhou Fushilai Pharmaceutical Co Quarterly Data
Jun18 Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.39 6.09 6.56 6.07 5.46

Competitive Comparison of Suzhou Fushilai Pharmaceutical Co's PS Ratio

For the Biotechnology subindustry, Suzhou Fushilai Pharmaceutical Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Suzhou Fushilai Pharmaceutical Co's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Suzhou Fushilai Pharmaceutical Co's PS Ratio distribution charts can be found below:

* The bar in red indicates where Suzhou Fushilai Pharmaceutical Co's PS Ratio falls into.



Suzhou Fushilai Pharmaceutical Co PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Suzhou Fushilai Pharmaceutical Co's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=26.26/4.667
=5.63

Suzhou Fushilai Pharmaceutical Co's Share Price of today is ¥26.26.
Suzhou Fushilai Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥4.67.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Suzhou Fushilai Pharmaceutical Co  (SZSE:301258) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Suzhou Fushilai Pharmaceutical Co PS Ratio Related Terms

Thank you for viewing the detailed overview of Suzhou Fushilai Pharmaceutical Co's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Suzhou Fushilai Pharmaceutical Co (SZSE:301258) Business Description

Traded in Other Exchanges
N/A
Address
No. 16, Haiwang Road, New Material Industrial Park, Jiangsu Province, Changshu, CHN, 215500
Suzhou Fushilai Pharmaceutical Co Ltd is engaged in the Research and development, production and sales of pharmaceutical intermediates, APIs and raw materials for health care products. The products are mainly used in the fields of medicine, dietary supplements and cosmetics, and have significant effects in anti-oxidation, anti-aging, and blood sugar improvement.
Executives
Qian Yi Supervisors

Suzhou Fushilai Pharmaceutical Co (SZSE:301258) Headlines

No Headlines